Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety and tolerability of multiple intravenous doses of MEDI-545 in adults with systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• MEDI-545

Snippet

Sponsor: MedImmune LLC | Conditions: Lupus | Phase 1 | Status: COMPLETED